Strategic Partnership Expands Opportunities for Enzyme Innovation
In 2024, we have entered a strategic partnership with Biodiscovery AS, a Norwegian marine bioprospecting company, for the collection and digitization of biological data for enzyme development. The partnership will contribute to the expansion of our existing MetXtra™ database. This will allow broader access to previously unexplored biodiversity and the discovery of new functionalities through rational bioprospecting of deep-sea metagenomes.
The partnership will also contribute to the development of further industrial enzymes with unique properties.
Biodiscovery AS will study deep-sea metagenomes from different locations and water depths in the North Sea and the Norwegian Sea. We will use these metagenomes to expand the existing sequence library of our MetXtra™ technology platform and to further improve its performance.
The MetXtra platform enables us and our customers to optimize biocatalytic processes, develop new enzyme solutions and support intellectual property rights. The proprietary, Nagoya-compliant metagenome database contains 99.8% novel sequences that are not publicly available, providing access to unique genetic diversity for pharmaceutical, food, feed, beverage and other industrial applications.
Picture: (C) Biodiscovery AS
“We and Biodiscovery AS will leverage our combined expertise to make new enzymes industrially accessible and viable, unlocking innovative opportunities for our customers. This will deliver significant value to those seeking novel, superior enzyme solutions.
It's more than just experience and knowledge
Alternative proteins continue to attract significant investment, precision fermentation is gaining commercial momentum, and consumer demand for health-focused products remains central to food and beverage development.
Deep-sea metagenomes provide access to unique genetic diversity for pharmaceutical, food, feed, beverage and other industrial applications
From maximising extract and improving lauter performance to supporting yeast health, clarity and shelf stability, enzymes quietly solve some of the brewing industry’s toughest challenges.
Implications for metagenomics, microbial strain collections, and enzyme discovery using digital sequence information
BRAINBiocatalysts supports the development of reliable, high-quality products while transforming side streams into valuable, sustainable solutions.
Vitafoods Europe 2026 made one thing very clear: the nutraceutical industry is entering a far more specialised and performance-driven era. While previous years focused heavily on broad wellness positioning and ingredient proliferation, this year’s conversations centred around functionality, precision, and measurable outcomes.
Here are seven reasons why companies partner with BRAINBiocatalysts to develop enzymes, production strains and bioprocesses.
There’s always a certain energy at Petfood Forum, and this year in Kansas City didn’t disappoint.
We caught up on the latest breakthroughs at the Future of Protein Production summit, where it’s clear the race to reinvent how we produce protein is well underway. Here’s a snapshot of the key trends, technologies, and takeaways shaping the future of food.
At BRAINBiocatalysts, we safeguard innovations from partners from the outset.
